These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3719370)

  • 41. Peptides in rat brain immunoreactive for the amino terminus of cholecystokinin 33: distribution and chromatography.
    Han SP; Allard LR; Beinfeld MC
    Biochem Biophys Res Commun; 1987 Dec; 149(3):902-7. PubMed ID: 3426615
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Capsaicin depletes CCK-like immunoreactivity detected by immunohistochemistry, but not that measured by radioimmunoassay in rat dorsal spinal cord.
    Schultzberg M; Dockray GJ; Williams RG
    Brain Res; 1982 Mar; 235(1):198-204. PubMed ID: 6765219
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Concentrations of mRNAs encoding for preprosomatostatin and preprocholecystokinin are increased after kainic acid-induced seizures.
    Olenik C; Meyer DK; Marksteiner J; Sperk G
    Synapse; 1989; 4(3):223-8. PubMed ID: 2575287
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cholecystokinin in feline vagal and sciatic nerves: concentration, molecular form and transport velocity.
    Rehfeld JF; Lundberg JM
    Brain Res; 1983 Sep; 275(2):341-7. PubMed ID: 6194857
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of nonsulfated cholecystokinin-58 in canine intestinal extracts and its biological properties.
    Reeve JR; Liddle RA; McVey DC; Vigna SR; Solomon TE; Keire DA; Rosenquist G; Shively JE; Lee TD; Chew P; Green GM; Coskun T
    Am J Physiol Gastrointest Liver Physiol; 2004 Aug; 287(2):G326-33. PubMed ID: 15064233
    [TBL] [Abstract][Full Text] [Related]  

  • 46. FMRFamide-like immunoreactivity in rat brain: development of a radioimmunoassay and its application in studies of distribution and chromatographic properties.
    Dockray GJ; Williams RG
    Brain Res; 1983 May; 266(2):295-303. PubMed ID: 6871665
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasma concentrations of cholecystokinin, CCK-8, and CCK-33, 39 in rats, determined by a method based on enzyme digestion of gastrin before HPLC and RIA detection of CCK.
    Lindén A; Carlquist M; Hansen S; Uvnäs-Moberg K
    Gut; 1989 Feb; 30(2):213-22. PubMed ID: 2703143
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Studies on the location and release of cholecystokinin and vasoactive intestinal peptide in rat and cat spinal cord.
    Yaksh TL; Abay EO; Go VL
    Brain Res; 1982 Jun; 242(2):279-90. PubMed ID: 6896838
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification and characterization of a novel CCK-like immunoreactive peptide in pig CNS.
    Varro A
    Neurochem Int; 1989; 14(4):505-10. PubMed ID: 20504457
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Alkaline extraction and characterization of cholecystokinin-immunoreactivity from rat gut.
    Ryder S; Eng J; Straus E; Yalow RS
    Gastroenterology; 1981 Aug; 81(2):267-75. PubMed ID: 7239135
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development of region-specific antisera for the C-terminal tetrapeptide of gastrin/cholecystokinin and their use in studies of immunoreactive forms of cholecystokinin in rat brain.
    Dockray GJ; Williams RG; Zhu WY
    Neurochem Int; 1981; 3(5):281-8. PubMed ID: 20487824
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regional distribution of the Mr 15,000 somatostatin precursor, somatostatin-28 and somatostatin-14 in the rat brain suggests a differential intracellular processing of the high molecular weight species.
    Gomez S; Morel A; Nicolas P; Cohen P
    Biochem Biophys Res Commun; 1983 Apr; 112(1):297-305. PubMed ID: 6132607
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cholecystokinin and vasoactive intestinal peptide in brain and gut of the hypothyroid neonatal rat.
    Zheng B; Eng J; Yalow RS
    Horm Metab Res; 1989 Mar; 21(3):127-31. PubMed ID: 2744718
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Radioimmunoassay of plasma cholecystokinin (CCK), duodenal release of CCK, diurnal variation of plasma CCK, and immunoreactive plasma CCK components in man.
    Burhol PG; Rayford PL; Jorde R; Waldum HL; Schulz TB; Thompson JC
    Hepatogastroenterology; 1980 Aug; 27(4):300-9. PubMed ID: 7193631
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nonsulfated cholecystokinins in cerebral neurons.
    Agersnap M; Zhang MD; Harkany T; Hökfelt T; Rehfeld JF
    Neuropeptides; 2016 Dec; 60():37-44. PubMed ID: 27535680
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cholecystokinin and its COOH-terminal octapeptide in the pig brain.
    Muller JE; Straus E; Yalow RS
    Proc Natl Acad Sci U S A; 1977 Jul; 74(7):3035-7. PubMed ID: 268651
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The release of rat intestinal cholecystokinin after oral trypsin inhibitor measured by bio-assay.
    Brand SJ; Morgan RG
    J Physiol; 1981; 319():325-43. PubMed ID: 7320918
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vivo studies on the basal and evoked release of cholecystokinin and vasoactive intestinal polypeptide from cat cerebral cortex and periventricular structures.
    Wang JY; Yaksh TL; Go VL
    Brain Res; 1983 Nov; 280(1):105-17. PubMed ID: 6652473
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunochemical studies relating to cholecystokinin in brain and gut.
    Straus E; Ryder SW; Eng J; Yalow RS
    Recent Prog Horm Res; 1981; 37():447-75. PubMed ID: 7025135
    [No Abstract]   [Full Text] [Related]  

  • 60. Ratio between large and small carboxy-terminal molecular forms of cholecystokinin in brains of different species.
    Jansen JB; Lamers CB
    Experientia; 1986 Dec; 42(11-12):1240-1. PubMed ID: 3491002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.